Quest Diagnostics Incorporated
DGX
Kedudukan dalam Saham
#930
Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus,... Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus, New Jersey, is a premier provider of diagnostic testing, information, and related services, serving clients both domestically and internationally. Its core business involves the development and provision of diverse diagnostic information services, such as routine, advanced clinical, and anatomic pathology testing. While primarily operating under the Quest Diagnostics brand, it also leverages specialized identities like AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum to reach a broad spectrum of clients. Its extensive client base includes patients, clinicians, hospitals, integrated delivery networks, health plans, employers, and other direct healthcare entities. Delivery of these services is facilitated through a robust network comprising laboratories, patient service centers, in-office phlebotomists, call centers, and mobile health professionals including paramedics and nurses. Additionally, the company provides risk assessment services for the life insurance industry and offers comprehensive information technology solutions to healthcare organizations and clinicians.
Harga Saham
$236.69
Disegerakkan terakhir: 2026-10-20
Modal Pasaran
$26.12B
Perubahan (1 hari)
0.80%
Perubahan (1 tahun)
28.19%
Negara
US
Perdagangan Quest Diagnostics Incorporated (DGX)
Kategori
Healthcare
Hasil untuk Quest Diagnostics Incorporated (DGX)
Hasil pada Jun 2026 TTM: $11.56B
Menurut laporan kewangan terkini daripada Quest Diagnostics Incorporated, hasil semasa syarikat (TTM) ialah $11.56B. Pada tahun 2024, syarikat memperoleh hasil sebanyak $9.87B peningkatan berbanding hasil pada tahun 2023 iaitu $9.25B. Hasil ialah jumlah pendapatan keseluruhan yang dijana oleh syarikat daripada jualan barangan atau perkhidmatan. Tidak seperti keuntungan, tiada perbelanjaan ditolak.
Sejarah hasil bagi Quest Diagnostics Incorporated dari 2000 hingga 2026
Hasil pada akhir setiap tahun
| Tahun | Hasil | Ubah |
|---|---|---|
| 2026 (TTM) | $11.56B | 4.76% |
| 2025 | $11.04B | 11.78% |
| 2024 | $9.87B | 6.70% |
| 2023 | $9.25B | -6.38% |
| 2022 | $9.88B | -8.39% |
| 2021 | $10.79B | 14.32% |
| 2020 | $9.44B | 22.15% |
| 2019 | $7.73B | 2.59% |
| 2018 | $7.53B | -2.31% |
| 2017 | $7.71B | 2.58% |
| 2016 | $7.52B | 0.29% |
| 2015 | $7.49B | 0.78% |
| 2014 | $7.44B | 4.04% |
| 2013 | $7.15B | -3.20% |
| 2012 | $7.38B | -1.70% |
| 2011 | $7.51B | 1.92% |
| 2010 | $7.37B | -1.16% |
| 2009 | $7.46B | 2.84% |
| 2008 | $7.25B | 8.12% |
| 2007 | $6.70B | 6.96% |
| 2006 | $6.27B | 13.90% |
| 2005 | $5.50B | 7.36% |
| 2004 | $5.13B | 8.20% |
| 2003 | $4.74B | 15.33% |
| 2002 | $4.11B | 13.24% |
| 2001 | $3.63B | 6.04% |
| 2000 | $3.42B | 0.00% |
Hasil untuk syarikat atau pesaing serupa
| Syarikat | Hasil | Perbezaan Hasil | Negara |
|---|---|---|---|
| $46.34B | 300.83% |
US
|
|
| $25.11B | 117.19% |
US
|
|
| $2.71B | -76.58% |
US
|
|
| - | - |
CN
|
|
| $7.37B | -36.23% |
US
|
